Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP289510.RAFU31UEG3AswBPC_9ADMCuXqimlPvlAxVVI8V0s-6QT8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP289510.RAFU31UEG3AswBPC_9ADMCuXqimlPvlAxVVI8V0s-6QT8130_assertion type Assertion NP289510.RAFU31UEG3AswBPC_9ADMCuXqimlPvlAxVVI8V0s-6QT8130_head.
- NP289510.RAFU31UEG3AswBPC_9ADMCuXqimlPvlAxVVI8V0s-6QT8130_assertion description "[We investigated the following SNPs: -1082, -819, -592 in the promoter region of IL10 in a normal (control) population and selected diseases: breast cancer (BrCa), systemic lupus erythematosus (SLE), and B-cell chronic lymphocytic leukemia (B-CLL) by denaturing high-performance liquid chromatography (DHPLC) and found distinct genotype and haplotype patterns.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP289510.RAFU31UEG3AswBPC_9ADMCuXqimlPvlAxVVI8V0s-6QT8130_provenance.
- NP289510.RAFU31UEG3AswBPC_9ADMCuXqimlPvlAxVVI8V0s-6QT8130_assertion evidence source_evidence_literature NP289510.RAFU31UEG3AswBPC_9ADMCuXqimlPvlAxVVI8V0s-6QT8130_provenance.
- NP289510.RAFU31UEG3AswBPC_9ADMCuXqimlPvlAxVVI8V0s-6QT8130_assertion SIO_000772 16030322 NP289510.RAFU31UEG3AswBPC_9ADMCuXqimlPvlAxVVI8V0s-6QT8130_provenance.
- NP289510.RAFU31UEG3AswBPC_9ADMCuXqimlPvlAxVVI8V0s-6QT8130_assertion wasDerivedFrom befree-20140225 NP289510.RAFU31UEG3AswBPC_9ADMCuXqimlPvlAxVVI8V0s-6QT8130_provenance.
- NP289510.RAFU31UEG3AswBPC_9ADMCuXqimlPvlAxVVI8V0s-6QT8130_assertion wasGeneratedBy ECO_0000203 NP289510.RAFU31UEG3AswBPC_9ADMCuXqimlPvlAxVVI8V0s-6QT8130_provenance.